APY Aspyra,

Aspyra, Inc. (AMEX: APY), a leading provider of clinical and diagnostic information solutions for the healthcare industry has entered into an agreement with Data Strategies, Inc. (DSI) allowing Aspyra to represent Data Strategies� elligence billing product line nationally to new and existing Aspyra customers. Data Strategies develops, manufactures and distributes products for healthcare practice management � much of the same audience for Aspyra�s clinical and diagnostic product solutions. Ade Lawal, Vice President of Strategy and Business Development for Aspyra stated, �Aspyra�s RIS, PACS and LIS solutions are designed to enhance the departmental workflow, boost productivity and reduce costs. With Data Strategies elligence, we can now offer new and existing customers a comprehensive integrated solution for the entire workflow process, not only enabling improved clinical efficiencies, but also quicker claim reimbursement and reduction in lost charges for the facility.� Les Jacobs, president and founder of DSI, stated �The core values of Data Strategies are consistent with that of Aspyra�s. Both companies strive to offer cost-effective solutions that provide the heatlhcare organization with powerful tools to achieve their clinical and business goals.� The non-exclusive national agreement became effective July 18, 2008 and is specific to Data Strategies elligence Healthcare Practice Management Billing software and all of its integrated modules and components. Aspyra solutions provide integrated technologies and services that improve the efficiency, safety and quality of patient care. Aspyra works directly with customers through its own sales and service staff as well as through an extensive partner network. The Company currently counts over 440 customers and over 650 application installations in its installed base. About Data Strategies Data Strategies, Inc. is a developer, manufacturer and distributor of products for healthcare practice management. Since 1982, thousands of healthcare providers around the U.S. rely on Data Strategies to accomplish mission-critical tasks: billing, appointment scheduling, EDI, reporting, practice management, and integration with clinical information management systems. For more information on Data Strategies, its products and services, visit www.elligence.net. About Aspyra Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com. Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of the date of this release, including management's own knowledge and assessment of the Company's industry, customers and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: changes in the Company�s management or other personnel, the competitive environment for Company products and services; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in the Company�s long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.